Acceptance of low-dose nicotine -- slow to arrive
Nicotine is much more than just a "stimulant." Credit: Garey Rademaker, you can see his interview on our YouTube page . Low-dose nicotine is much more than just a stimulant I knew that it would take a while for people to accept low-dose nicotine as a treatment for Long Covid, MECFS, fibromyalgia, etc... but I have been surprised that it would take years. I personally needed to do a lot of research before trying the treatment; however, the large number of people who see clinically significant results has been ignored or mistaken for a stimulant that just gives "fake energy." There are decades of scientific publications that explain how low-dose nicotine patches benefit us through multiple pathways. And if prompted correctly, AI is now "mostly" able to distinguish between the benefits of low-dose patching and the downsides of smoking. AI even cites our research . I am happy to see that various LC (long-COVID) experts are including low-dose nicotine patches i...